Fifth Third Bancorp Sells 2,629 Shares of Bath & Body Works, Inc. $BBWI

Fifth Third Bancorp reduced its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 61.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,645 shares of the company’s stock after selling 2,629 shares during the period. Fifth Third Bancorp’s holdings in Bath & Body Works were worth $49,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of BBWI. Forte Capital LLC ADV purchased a new stake in Bath & Body Works during the second quarter valued at about $218,000. Kwmg LLC lifted its position in Bath & Body Works by 10.6% during the second quarter. Kwmg LLC now owns 160,405 shares of the company’s stock valued at $4,806,000 after purchasing an additional 15,433 shares in the last quarter. Revisor Wealth Management LLC purchased a new position in shares of Bath & Body Works in the second quarter valued at about $245,000. Park Avenue Securities LLC purchased a new stake in shares of Bath & Body Works in the second quarter valued at $209,000. Finally, UMB Bank n.a. increased its holdings in shares of Bath & Body Works by 85.8% in the 2nd quarter. UMB Bank n.a. now owns 2,789 shares of the company’s stock valued at $84,000 after acquiring an additional 1,288 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Trading Up 0.1%

BBWI stock opened at $25.69 on Friday. The firm has a market capitalization of $5.30 billion, a P/E ratio of 7.62, a price-to-earnings-growth ratio of 0.87 and a beta of 1.52. Bath & Body Works, Inc. has a 12 month low of $24.93 and a 12 month high of $41.87. The firm has a 50 day moving average of $28.53 and a 200-day moving average of $29.50.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.37. The company had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm’s revenue for the quarter was down .8% on a year-over-year basis. During the same quarter last year, the company earned $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 3.1%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works’s dividend payout ratio is currently 23.74%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on BBWI shares. Citigroup decreased their target price on Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a research report on Tuesday, August 19th. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $38.00 price target on shares of Bath & Body Works in a report on Thursday, August 28th. Morgan Stanley dropped their target price on Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating on the stock in a report on Friday, September 12th. Wall Street Zen cut shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Finally, Barclays raised their price objective on Bath & Body Works from $30.00 to $32.00 and gave the stock an “equal weight” rating in a research report on Friday, August 29th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $39.69.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.